CSPC Pharmaceutical Group Limited (CHJTF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CSPC Pharmaceutical Group...

    OTC: CHJTF · Real-Time Price · USD
    1.27
    0.00 (0.00%)
    At close: Aug 05, 2025, 12:35 PM
    1.27
    0.00%
    After-hours: Sep 03, 2025, 08:00 PM EDT

    CSPC Pharmaceutical Income Statement

    Financials in HKD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 30.87B 34.6B 31.59B 33.59B
    Cost of Revenue
    		 9.27B 10.2B 8.86B 8.11B
    Gross Profit
    		 21.6B 24.4B 22.73B 25.47B
    Operating Income
    		 5.71B 7.68B 6.76B 6.25B
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 5.94B 7.39B 7.58B 6.85B
    Net Income
    		 4.61B 5.87B 6.09B 5.61B
    Selling & General & Admin
    		 10.37B 11.36B 13.03B 14.05B
    Research & Development
    		 5.52B 5.34B 3.99B 3.43B
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 15.89B 16.72B 15.8B 17.95B
    Interest Expense
    		 43.67M 25.9M 24.89M 7.66M
    Selling & Marketing Expenses
    		 9.22B 10.06B 11.7B 12.81B
    Cost & Expenses
    		 25.16B 26.92B 24.66B 26.06B
    Income Tax Expense
    		 1.32B 1.32B 1.38B 1.4B
    Shares Outstanding (Basic)
    		 11.74B 11.87B 11.92B 11.95B
    Shares Outstanding (Diluted)
    		 11.74B 11.87B 11.92B 11.95B
    EPS (Basic)
    		 0.39 0.49 0.52 0.57
    EPS (Diluted)
    		 0.39 0.49 0.52 0.57
    EBITDA
    		 6.96B 8.53B 8.66B 9.28B
    EBIT
    		 5.71B 7.42B 7.61B 8.23B
    Depreciation & Amortization
    		 1.34B 1.12B 1.05B 1.04B

    Add to Watchlist